Added to YB: 2017-03-16
Pitch date: 2017-03-16
KDMN:US [bullish]
Kadmon Holdings, Inc.
+162.43%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases.
Market Cap
$1.7B
Pitch Price
$3.62
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-13.33
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
KADMON HOLDINGS INC KDMN:US
A summary for this pitch has not been created yet.
Read full article (0 min)